Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors
for Solid Tumors
Sites in Rochester +5 more locations
Sponsor: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
Sex: All·Age: 18 - 75
Code: NCT06963281·Phase 1·Recruiting·Listed May 2025